Literature DB >> 18602481

Hippocampal hyperperfusion in Alzheimer's disease.

David C Alsop1, Melynda Casement, Cedric de Bazelaire, Tamara Fong, Daniel Z Press.   

Abstract

Many of the regions with the earliest atrophy in Alzheimer's Disease (AD) do not show prominent deficits on functional imaging studies of flow or metabolism. This paradox may provide unique insights into the pathophysiology of AD. We sought to examine the relationship between function and atrophy in AD using MRI blood flow and anatomic imaging. 22 subjects diagnosed with AD, mean Mini Mental State Exam (MMSE) score 22.2, and 16 healthy elderly controls were imaged with a volumetric arterial spin labeling blood flow MRI technique and an anatomical imaging method using the identical spatial resolution, image orientation, and spatial encoding strategy. Cerebral blood flow (CBF) and gray matter (GM) maps derived from the imaging were transformed to a standard anatomical space. GM and CBF maps were tested for significant differences between groups. Additionally, images were tested for regions with significant mismatch of the CBF and GM differences between groups. CBF was significantly lower in the bilateral precuneus, parietal association cortex and the left inferior temporal lobe but was non-significantly increased in the hippocampus and other medial temporal structures. After correction for GM loss, CBF was significantly elevated in the hippocampus and other medial temporal structures. The hippocampus and other regions affected early in AD are characterized by elevated atrophy-corrected perfusion per cm(3) of tissue. This suggests compensatory or pathological elevation of neural activity, inflammation, or elevated production of vasodilators.

Entities:  

Mesh:

Year:  2008        PMID: 18602481      PMCID: PMC2675915          DOI: 10.1016/j.neuroimage.2008.06.006

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  59 in total

1.  Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging.

Authors:  D C Alsop; J A Detre; M Grossman
Journal:  Ann Neurol       Date:  2000-01       Impact factor: 10.422

Review 2.  A plasticity-based theory of the pathogenesis of Alzheimer's disease.

Authors:  M M Mesulam
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

3.  SPECT imaging in dementias.

Authors:  F J Bonte; M F Weiner; E H Bigio; C L White
Journal:  J Nucl Med       Date:  2001-07       Impact factor: 10.057

4.  Hippocampal formation glucose metabolism and volume losses in MCI and AD.

Authors:  S De Santi; M J de Leon; H Rusinek; A Convit; C Y Tarshish; A Roche; W H Tsui; E Kandil; M Boppana; K Daisley; G J Wang; D Schlyer; J Fowler
Journal:  Neurobiol Aging       Date:  2001 Jul-Aug       Impact factor: 4.673

5.  Effects of damage to the basal forebrain on brain glucose utilization: a reevaluation using positron emission tomography in baboons with extensive unilateral excitotoxic lesion.

Authors:  C Le Mestric; C Chavoix; F Chapon; F Mézenge; J Epelbaum; J C Baron
Journal:  J Cereb Blood Flow Metab       Date:  1998-05       Impact factor: 6.200

6.  In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease.

Authors:  J C Baron; G Chételat; B Desgranges; G Perchey; B Landeau; V de la Sayette; F Eustache
Journal:  Neuroimage       Date:  2001-08       Impact factor: 6.556

7.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

8.  Quantitation of regional cerebral blood flow corrected for partial volume effect using O-15 water and PET: I. Theory, error analysis, and stereologic comparison.

Authors:  H Iida; I Law; B Pakkenberg; A Krarup-Hansen; S Eberl; S Holm; A K Hansen; H J Gundersen; C Thomsen; C Svarer; P Ring; L Friberg; O B Paulson
Journal:  J Cereb Blood Flow Metab       Date:  2000-08       Impact factor: 6.200

9.  Hippocampal perfusion in mild Alzheimer's disease.

Authors:  G Rodriguez; P Vitali; P Calvini; C Bordoni; N Girtler; G Taddei; G Mariani; F Nobili
Journal:  Psychiatry Res       Date:  2000-12-04       Impact factor: 3.222

10.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease.

Authors:  R J Killiany; T Gomez-Isla; M Moss; R Kikinis; T Sandor; F Jolesz; R Tanzi; K Jones; B T Hyman; M S Albert
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

View more
  78 in total

Review 1.  Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.

Authors:  Oscar L Lopez; James T Becker; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?

Authors:  Tamara G Fong; Sharon K Inouye; Weiying Dai; Daniel Z Press; David C Alsop
Journal:  Brain Imaging Behav       Date:  2011-03       Impact factor: 3.978

3.  Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer's Disease.

Authors:  Wenna Duan; Parshant Sehrawat; Arvind Balachandrasekaran; Ashish B Bhumkar; Paresh B Boraste; James T Becker; Lewis H Kuller; Oscar L Lopez; H Michael Gach; Weiying Dai
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 4.  Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.

Authors:  Christina E Wierenga; Chelsea C Hays; Zvinka Z Zlatar
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

5.  Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions.

Authors:  David A Wolk; John A Detre
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

6.  Distinct medial temporal contributions to different forms of recognition in amnestic mild cognitive impairment and Alzheimer's disease.

Authors:  Carmen Westerberg; Andrew Mayes; Susan M Florczak; Yufen Chen; Jessica Creery; Todd Parrish; Sandra Weintraub; M-Marsel Mesulam; Paul J Reber; Ken A Paller
Journal:  Neuropsychologia       Date:  2013-07-04       Impact factor: 3.139

7.  Regional correlation between resting state FDG PET and pCASL perfusion MRI.

Authors:  Yoon-Hee K Cha; Mayank A Jog; Yoon-Chung Kim; Shruthi Chakrapani; Stephen M Kraman; Danny J J Wang
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

8.  Comparison of PASL, PCASL, and background-suppressed 3D PCASL in mild cognitive impairment.

Authors:  Sudipto Dolui; Marta Vidorreta; Ze Wang; Ilya M Nasrallah; Abass Alavi; David A Wolk; John A Detre
Journal:  Hum Brain Mapp       Date:  2017-07-24       Impact factor: 5.038

9.  Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease.

Authors:  Guofan Xu; Howard A Rowley; Gaohong Wu; David C Alsop; Ajit Shankaranarayanan; Maritza Dowling; Bradley T Christian; Terrence R Oakes; Sterling C Johnson
Journal:  NMR Biomed       Date:  2010-04       Impact factor: 4.044

10.  Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.

Authors:  Renaud La Joie; Audrey Perrotin; Louisa Barré; Caroline Hommet; Florence Mézenge; Méziane Ibazizene; Vincent Camus; Ahmed Abbas; Brigitte Landeau; Denis Guilloteau; Vincent de La Sayette; Francis Eustache; Béatrice Desgranges; Gaël Chételat
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.